Health News: [cancer]

Press Release PharmiWeb Thu, 26 Jan 2012 06:00 AM PST Advaxis Inc. Posted on:26 Jan 12 Advaxis, Inc . , (OTCBB: ADXS) , a leader in developing the next generation of immunotherapies for cancer and infectious diseases, reported preliminary data on the safety and clinical benefit of ADXS-HPV from an ongoing randomized Phase 2 trial of ADXS-HPV with or without cisplatin in Indian women with recurrent/refractory cervical cancer who have failed ... Amgen to buy Micromet for $1.16 billion Times Leader Thu, 26 Jan 2012 05:58 AM PST (AP) Amgen Inc. is buying Micromet Inc., a developer of cancer therapies, for $1.16 billion in cash in a bid to boost its oncology pipeline. CCA membership meeting on Tuesday Saipan Tribune Thu, 26 Jan 2012 05:57 AM PST All clients, partners, donors, volunteers, and other friends of the Commonwealth Cancer Association are invited to CCA's Annual General Membership Meeting, slated for Tuesday, Jan. 31, 2012, at 6pm in the CCA conference room in Gualo Rai. State College grieves Paterno The Toledo Blade Thu, 26 Jan 2012 05:56 AM PST STATE COLLEGE, Pa. â€" Joe Paterno’s death from lung cancer Sunday just two months after his firing left many Penn State students, alumni and community members numb with grief and a sense that the legendary coach deserved better from the university after such a distinguished career. Cares for Cancer The Wahpeton Daily News Thu, 26 Jan 2012 05:53 AM PST Cares for Cancer will be having its annual benefit Saturday, March 31 at the American Legion Hall in Hankinson. The “head”liner is Karly Steinwehr, the first woman in the history of the event to have her head shaved during the fundraiser. Cares for Cancer is hoping to raise $5,000 for her hair. BioReference to Launch Groundbreaking Solid Tumor Genotyping Test through its GenPath Oncology Laboratory Business Wire Thu, 26 Jan 2012 05:50 AM PST ELMWOOD PARK, N.J.--(BUSINESS WIRE)--BioReference Laboratories, Inc. (NASDAQ: BRLI) and its GenPath Oncology business unit and through its exclusive commercialization agreement with the Massachusetts General Hospital (MGH) is introducing its groundbreaking solid tumor genotype test. The test â€" which will be marketed as OnkoMatchTM â€" will help oncologists match patients with cancer therapies ... HCG Ahmedabad Becomes First Hospital in India to Deliver Advanced Radiotherapy Treatments ... ThomasNet Thu, 26 Jan 2012 05:49 AM PST Leading Cancer Center in Ahmedabad Commences Treatments Using Varian TrueBeam Linear Accelerator AHMEDABAD, India - A 65-year-old breast cancer patient has become the first person in India to be treated using the fast and precise TrueBeam(TM) radiotherapy treatment system from Varian Medical Systems (NYSE:VAR). In a treatment carried out at HCG (Health Care Global) Ahmedabad, the patient ... REPEAT/Advaxis Reports Preliminary Safety and Survival Data from a Phase 2 Trial in Recurrent/Refractory Cervical Cancer Business Wire Thu, 26 Jan 2012 05:49 AM PST PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, reported preliminary data on the safety and clinical benefit of ADXS-HPV from an ongoing randomized Phase 2 trial of ADXS-HPV with or without cisplatin in Indian women with recurrent/refractory cervical cancer who have failed cytotoxic ... Amgen to Buy Micromet for More Than $1 Billion CNBC Thu, 26 Jan 2012 05:45 AM PST Amgen , the world's largest biotechnology company, said on Thursday it would pay over $1 billion to buy Micromet , which has several cancer drugs in development. Amgen Acquires Micromet for $1.16 Billion TheStreet.com Thu, 26 Jan 2012 05:44 AM PST THOUSAND OAKS, Calif. (TheStreet) -- Amgen is acquiring Micromet, a mid-stage developer of blood cancer drugs, in an all-cash deal worth $1.16 billion, the companies announced Thursday. The Amgen buyout values Micromet at $11 per share, or a 33% premium to the stock's closing price of $8.28 per share on Wednesday. Micromet's lead drug, blinatumomab, is in a phase II clinical trials for acute ...

See more health stories that match my keyword Visit Yahoo! Health

You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.